Background: Attention deficit hyperactivity disorder (ADHD) is a prevalent and multifactorial neuropsychiatric disorder in the human population worldwide. Complex etiology and clinical heterogeneity have challenged the research, diagnostics and treatment of the disease. Hyperactive and impulsive behaviour has also been observed in dogs, and they could offer a physiologically relevant model for human ADHD. As a part of our ongoing study to understand the molecular etiology of canine anxiety traits, this study was aimed to pilot an approach to identify metabolic biomarkers in canine ADHD-like behaviours for research, diagnostics and treatment purposes.
Methods: We collected fresh plasma samples from 22 German Shepherds with varying ADHD-like behaviours. All dogs were on the same controlled diet for 2 weeks prior to sampling. A liquid chromatography combined with mass spectrometry (LC-MS)-based non-targeted metabolite profiling was performed to identify plasma metabolites correlating with the ADHD-like behaviour of the dogs.
Results: 649 molecular features correlated with ADHD-like behavioural scores (p < 0.05), and three of them [sn-1 LysoPC(18:3), PC(18:3/18:2) and sn-1 LysoPE(18:2)] had significant correlations also after FDR correction (pFDR < 0.05). Phospholipids were found to negatively correlate with ADHD-like behavioural scores, whereas tryptophan metabolites 3-indolepropionic acid (IPA) and kynurenic acid (KYNA) had negative and positive correlations with ADHD-like behavioural scores, respectively.
Conclusions: Our study identified associations between canine ADHD-like behaviours and metabolites that are involved in lipid and tryptophan metabolisms. The identified metabolites share similarity with earlier findings in human and rodent ADHD models. However, a larger replication study is warranted to validate the discoveries prior to further studies to understand the biological role of the identified metabolites in canine ADHD-like behaviours.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043524 | PMC |
| http://dx.doi.org/10.1186/s12993-016-0112-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Deficiency of histamine H receptors in parvalbumin-positive neurons leads to hyperactivity, impulsivity, and impaired attention.
Neuron
January 2025
Department of Pharmacology and Department of Pharmacy of the Second Affiliated Hospital, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou 310058, China. Electronic address:
Attention deficit hyperactivity disorder (ADHD), affecting 4% of the population, is characterized by inattention, hyperactivity, and impulsivity; however, its neurophysiological mechanisms remain unclear. Here, we discovered that deficiency of histamine H receptor (HR) in parvalbumin-positive neurons in substantia nigra pars recticulata (PV) attenuates PV neuronal activity and induces hyperactivity, impulsivity, and inattention in mice. Moreover, decreased HR expression was observed in PV in patients with ADHD symptoms and dopamine-transporter-deficient mice, whose behavioral phenotypes were alleviated by HR agonist treatment.
View Article and Find Full Text PDFAberrant extracellular dopamine clearance in the prefrontal cortex exhibits ADHD-like behavior in NCX3 heterozygous mice.
FEBS J
January 2025
Research Center for Pharmaceutical Development, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Article Synopsis
- ADHD is linked to dopaminergic dysfunction in the prefrontal cortex, leading to symptoms like hyperactivity, inattention, and cognitive deficits.
- Researchers identified sodium-calcium exchanger 3 (NCX3) in dopaminergic neurons, finding that its knockdown causes abnormal dopamine influx and related behavioral issues in mice.
- NCX3 heterozygous mice display ADHD-like behaviors, such as hyperactivity and cognitive deficits, which can be improved with methylphenidate, highlighting the role of NCX3 in dopamine signaling and ADHD.
[Advances in the Pathophysiology and Drug Discovery of Novel Therapeutics for Attention-Deficit/hyperactivity Disorder].
Yakugaku Zasshi
December 2024
Department of Pharmacology, Faculty of Pharmaceutical Science, Health Sciences University of Hokkaido.
Article Synopsis
- ADHD is a neurodevelopmental disorder marked by inattention, hyperactivity, and impulsivity, typically treated with psychostimulants like methylphenidate, which have significant side effects and addiction risks.
- * The study used juvenile stroke-prone spontaneously hypertensive rats (SHRSP/Ezo) to explore D-serine levels and NMDA receptor dysfunction in relation to ADHD, finding a lower D-serine/total serine ratio in these rats compared to control rats.
- * Inhibiting DAAO in the mPFC improved the D-serine levels and reduced ADHD-like behaviors in SHRSP/Ezo, suggesting that D-serine metabolism may play a key role in ADHD's pathogenesis and pointing towards potential new treatments
Delay of Gratification in Preschoolers with Autism and Concerns for ADHD.
J Clin Child Adolesc Psychol
October 2024
Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California.
Objective: Self-regulation abilities in childhood are predictive of a range of challenges later in life, making it important to identify difficulties in this area as early as possible. Autistic children and those with attention-deficit/hyperactivity disorder (ADHD) often have difficulties with self-regulation, but little is known about the similarities and differences in such abilities across neurodevelopmental conditions.
Method: We examined self-regulation using a delay of gratification task in 36-month-old autistic children ( = 20), those showing clinically relevant concerns for ADHD (i.
Impact of Serotonin Transporter Absence on Brain Insulin Receptor Expression, Plasma Metabolome Changes, and ADHD-like Behavior in Mice fed a Western Diet.
Biomolecules
July 2024
Department of Pharmacology, Oxford University, Oxford OX1 3QT, UK.
The impaired function of the serotonin transporter (SERT) in humans has been linked to a higher risk of obesity and type 2 diabetes, especially as people age. Consuming a "Western diet" (WD), which is high in saturated fats, cholesterol, and sugars, can induce metabolic syndrome. Previous research indicated that mice carrying a targeted inactivation of the gene (knockout, KO) and fed a WD display significant metabolic disturbances and behaviors reminiscent of ADHD.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!